E-LIB Suche - Ergebnisse für: Musacchio, Lucia

1

Unlocking the potential of Molecular Tumor Boards: from cut..:

Pastò, Brenno ; Buzzatti, Giulia ; Schettino, Clorinda...
Critical Reviews in Oncology/Hematology. 199 (2024) - p. 104379 , 2024

Link: https://doi.org/10.1016/..

2

Real world data of niraparib in platinum sensitive relapsed..:

Musacchio, Lucia ; Palluzzi, Eleonora ; Di Napoli, Marilena...
Gynecologic Oncology. 184 (2024) - p. 24-30 , 2024

Link: https://doi.org/10.1016/..

3

Incorporation of anti-PD1 or anti PD-L1 agents to platinum-..:

Bartoletti, Michele ; Montico, Marcella ; Lorusso, Domenica...
Cancer Treatment Reviews. 125 (2024) - p. 102701 , 2024

Link: https://doi.org/10.1016/..

4

The role of immunotherapy in advanced and recurrent MMR def..:

Di Dio, Camilla ; Bogani, Giorgio ; Di Donato, Violante...
Gynecologic Oncology. 169 (2023) - p. 27-33 , 2023

Link: https://doi.org/10.1016/..

5

Therapeutic Potential of Tisotumab Vedotin in the Treatment..:

Agostinelli, Veronica ; Musacchio, Lucia ; Camarda, Floriana...
Cancer Management and Research. 15 (2023) - p. 1063-1072 , 2023

Link: https://doi.org/10.2147/..

6

Effect of bevacizumab in advanced low grade serous ovarian ..:

Musacchio, Lucia ; Turinetto, Margherita ; Arenare, Laura...
Gynecologic Oncology. 172 (2023) - p. 72-77 , 2023

Link: https://doi.org/10.1016/..

7

Dostarlimab: From preclinical investigation to drug approva..:

Cicala, Carlo Maria ; Musacchio, Lucia ; Scambia, Giovanni.
Human Vaccines & Immunotherapeutics. 19 (2023) 1 - p. , 2023

Link: https://doi.org/10.1080/..

8

Preclinical and Clinical Evidence of Lurbinectedin in Ovari..:

Musacchio, Lucia ; Cicala, Carlo Maria ; Salutari, Vanda...
Frontiers in Oncology. 12 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

9

PARP Inhibitors Resistance: Mechanisms and Perspectives:

Giudice, Elena ; Gentile, Marica ; Salutari, Vanda...
Cancers. 14 (2022) 6 - p. 1420 , 2022

Link: https://doi.org/10.3390/..

10

Advanced and recurrent endometrial cancer: State of the art..:

Tronconi, Francesca ; Nero, Camilla ; Giudice, Elena...
Critical Reviews in Oncology/Hematology. 180 (2022) - p. 103851 , 2022

Link: https://doi.org/10.1016/..

11

MEK inhibitor as single agent in low grade serous ovarian a..:

Musacchio, Lucia ; Valsecchi, Anna Amela ; Salutari, Vanda...
Cancer Treatment Reviews. 110 (2022) - p. 102458 , 2022

Link: https://doi.org/10.1016/..

12

Clinical characteristics and molecular aspects of low-grade..:

Musacchio, Lucia ; Califano, Daniela ; Bartoletti, Michele...
British Journal of Cancer. 127 (2022) 8 - p. 1479-1486 , 2022

Link: https://doi.org/10.1038/..

13

Efficacy and safety of trabectedin for the treatment of adv..:

Lorusso, Domenica ; Pignata, Sandro ; Tamberi, Stefano...
Gynecologic Oncology. 167 (2022) 3 - p. 436-443 , 2022

Link: https://doi.org/10.1016/..

14

Gut microbiota and its influence on ovarian cancer carcinog..:

Giudice, Elena ; Salutari, Vanda ; Ricci, Caterina...
Critical Reviews in Oncology/Hematology. 168 (2021) - p. 103542 , 2021

Link: https://doi.org/10.1016/..

15

Refining Adjuvant Therapy for Endometrial Cancer: New Stand..:

Giustozzi, Alessandra ; Salutari, Vanda ; Giudice, Elena...
Biology. 10 (2021) 9 - p. 845 , 2021

Link: https://doi.org/10.3390/..